Using 4NQO-LCSF-1 and 4NQO-LGFP tumors we provided further evidence to support the influence of tumor-derived CSF-1 on CSF-1R+CD11c+ MDSCs and CD8+ T cells in response to therapy in vivo. The gene discussed is ITGAX; the disease is neoplasm.